Carotenoid Supplementation and Retinal Health in Healthy Adults
This study is looking at how taking a carotenoid supplement affects the health of your retina, which is the light-sensitive tissue at the back of your eye. Researchers want to see if this supplement can improve your macular pigment optical density (MPOD), a protective feature in your eye, and reduce retinal waste. You would take either a carotenoid supplement or a placebo (a pill with no active ingredients) daily for 3 months. To join, you need to be a healthy adult between 18 and 75 years old with good vision and no history of eye or serious health problems. The study will measure changes in your MPOD and a measure of retinal brightness to see if the supplement is successful. The current status of this study is unclear, and it plans to enroll 50 participants.
- Study design
- This is an interventional study planning to enroll 50 healthy adults. Participants will be randomly assigned to receive either a carotenoid supplement or a placebo.
- What's involved
- You would take one softgel capsule daily with a meal for 3 months. Measurements will be taken from when you start until the end of the 3-month treatment period.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 3 months, from enrollment to the end of treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Carotenoid Supplementation and Retinal Health in Healthy Adults
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change From Baseline in Macular Pigment Optical Density (MPOD) in Density Units Over 3 MonthsFrom enrollment to the end of treatment at 3 months
- Change From Baseline in Fundus Autofluorescence (FAF) Brightness in Pixels Over 3 MonthsFrom enrollment to the end of treatment at 3 months